The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders

Schizophr Res. 2018 May:195:513-518. doi: 10.1016/j.schres.2017.08.059. Epub 2017 Sep 18.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use
  • Cholesterol, HDL / metabolism
  • Female
  • Humans
  • Male
  • Metabolic Diseases / etiology*
  • Middle Aged
  • Psychiatric Status Rating Scales
  • Psychotic Disorders / complications
  • Psychotic Disorders / epidemiology
  • Psychotic Disorders / metabolism*
  • Psychotic Disorders / therapy
  • Vitamin D / administration & dosage
  • Vitamin D / blood
  • Vitamin D Deficiency / epidemiology*
  • Vitamin D Deficiency / etiology*

Substances

  • Antipsychotic Agents
  • Cholesterol, HDL
  • Vitamin D